272 related articles for article (PubMed ID: 2143956)
21. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
Eltze M
Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
[TBL] [Abstract][Full Text] [Related]
22. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
[TBL] [Abstract][Full Text] [Related]
23. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
Nakae I; Quan L; Sugimoto Y; Tsutamoto T; Kinoshita M
J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments.
Ishiyama T; Dohi S; Iida H; Akamatsu S; Ohta S; Shimonaka H
Stroke; 1994 Aug; 25(8):1644-50. PubMed ID: 8042218
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
Kreye VA; Lenz T; Pfründer D; Theiss U
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
[TBL] [Abstract][Full Text] [Related]
26. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
27. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
[TBL] [Abstract][Full Text] [Related]
28. Comparative electrophysiological and mechanical actions of ATP-sensitive potassium channel openers in canine Purkinje fibers.
Satoh H
Gen Pharmacol; 1993 May; 24(3):565-75. PubMed ID: 8365637
[TBL] [Abstract][Full Text] [Related]
29. Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs.
Spinelli W; Follmer C; Parsons R; Colatsky T
Eur J Pharmacol; 1990 Apr; 179(3):243-52. PubMed ID: 2142089
[TBL] [Abstract][Full Text] [Related]
30. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
Pratz J; Mondot S; Montier F; Cavero I
J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
[TBL] [Abstract][Full Text] [Related]
31. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
Yanagisawa T; Hashimoto H; Taira N
Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
[TBL] [Abstract][Full Text] [Related]
32. Potentiating effect of nicorandil on the adenosine A2 receptor-mediated vasodepression in rats: potential role for KATP channels.
Saito K; Sakai K
Fundam Clin Pharmacol; 1998; 12(2):143-51. PubMed ID: 9565767
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of KRN2391 in canine coronary vascular bed.
Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
[TBL] [Abstract][Full Text] [Related]
34. Interaction of potassium channel openers and blockers in canine atrial muscle.
Yanagisawa T; Hashimoto H; Taira N
Br J Pharmacol; 1989 Jul; 97(3):753-62. PubMed ID: 2527073
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs.
Berdeaux A; Drieu la Rochelle C; Richard V; Giudicelli JF
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S17-21. PubMed ID: 1282171
[TBL] [Abstract][Full Text] [Related]
36. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
[TBL] [Abstract][Full Text] [Related]
37. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
Satoh H
J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H
Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876
[TBL] [Abstract][Full Text] [Related]
39. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs.
Hirata Y; Aisaka K
J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679
[TBL] [Abstract][Full Text] [Related]
40. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery.
Zhou Q; Satake N; Shibata S
Eur J Pharmacol; 1995 Jan; 273(1-2):153-9. PubMed ID: 7737309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
